"He eventually muttered, 'You're right, everyone's always been right. I can't believe I got to this point' and kept bawling ...

Nvidia, the chip company that’s become the poster child of the AI rush ... Shares of vaccine maker Moderna slid close to 5% on a media report that the Trump administration is considering pulling ...

The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Diabetes, Cancer), Dosage Form, ...

Real-time index price for TSX Preferred Share Index (TXPR), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

We're inviting attendees to showcase their work and present a poster as part of the conference programme ... We're pleased to welcome Moderna as a sponsor for this year's Cancer Prevention Research ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever received at the company. The 16.4% increase—at grant value—came ...

Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said. The review is part of a ...

HHS cites need for review due to 'oversight' issues CDC states low risk of H5 bird flu to public Moderna's shares drop 5.5% Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million ...